Compare Injective (INJ) vs Bittensor (TAO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Injective vs Bittensor — how do they compare? Injective trades at Rp93,312 (market cap Rp9,34T, Rp1,71T 24h volume), while Bittensor trades at Rp3,618,426 (market cap Rp40,46T, Rp2,84T 24h volume). The key difference: Bittensor is far larger — about 4.3× Injective's market cap, and Bittensor's supply is capped (11,1M / 21M TAO (53%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and Bittensor for 42 Days on average.
| INJ | TAO | |
|---|---|---|
Market Cap | Rp9,34T | Rp40,46T |
Volume (24h) | Rp1,71T | Rp2,84T |
Circulating Supply | 100M INJ | 11,1M / 21M TAO (53%) |
Typical Hold Time | 36 Days | 42 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Injective (INJ) is trading at Rp90,066 with a market cap of Rp8.94 trillion, exhibiting a bullish technical signal supported by moving averages while oscillators remain neutral. The current price sits above key support levels, with resistance near Rp93,589. Recent on-chain data indicates an average hold time of 36 days, suggesting moderate holder confidence. No major protocol upgrades or ecosystem news have been reported recently, keeping fundamental developments quiet.
Overall outlook is cautiously optimistic due to bullish technicals, but key risks include high volatility and neutral oscillators signaling potential overbought conditions. Opportunities lie in continued network adoption, while investors should monitor regulatory developments and liquidity depth closely. Major risks involve crypto market volatility and lack of recent fundamental catalysts.
Bittensor (TAO) is currently trading at Rp3,677,988 with a market cap of Rp41.01T, showing a bearish technical signal across moving averages and oscillators. The price is near the pivot point of Rp3,685,708, with immediate support at Rp3,538,310. Recent ecosystem developments include strategic advisor appointments and growing institutional recognition in decentralized AI, though on-chain activity remains moderate with a 53% circulation rate.
Overall outlook is cautious due to strong bearish momentum, but oversold RSI hints at potential short-term rebounds. Key opportunities lie in TAO's positioning in decentralized AI; major risks include high volatility, regulatory uncertainty, and low liquidity depth. Investors should monitor key support levels for entry points.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Injective
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →About Bittensor
Bittensor is an open-source protocol that powers a decentralized, blockchain-based machine learning network. Machine learning models train collaboratively and are rewarded in TAO according to the informational value they offer the collective. TAO also grants external access, allowing users to extract information from the network while tuning its activities to their needs.
Read more on TAO →
